We don't have empirical evidence that would point to that necessarily. What we do have is analysis in terms of the trend, in terms of ticket prices in Canada. I mean, that's something that the NACC has worked on, and it showed that mean prices have dropped domestically.
Internationally we look at that, but we don't have anything that points to prices going up necessarily if these joint ventures are authorized, at least in the short term. What we do know is that we have evidence that they already hold dominant or fortress market shares in 20 of 30 transatlantic markets. This is the joint venture we're talking about that's of relevance, Atlantic plus, plus. As such, we're saying the chances are pretty good that, if this operation is immunized, protected, or exempted from competition law enforcement, there's a risk in terms of abusing that dominant position.
We're not accusing these companies of going to do that or doing that right now, absolutely not. What we're saying, though, is that you are more at risk for that sort of behaviour in terms of higher prices, because any economist will tell you, once you control a certain amount of market share in a defined market, you have an inordinate ability and power to drive pricing to your interest in that market, not necessarily to the consumer interest. That's not me talking. Any economist in any competitive market will tell you that.
What we're doing here, I think, goes against that. It basically confirms that wisdom.